Mind Medicine (MindMed) (MNMD) Competitors $7.20 +0.12 (+1.69%) Closing price 07/3/2025 03:57 PM EasternExtended Trading$7.15 -0.05 (-0.69%) As of 07/3/2025 04:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipShort InterestTrendsBuy This Stock MNMD vs. AGIO, INDV, IDYA, BLTE, IRON, HRMY, ADPT, CNTA, SPRY, and BEAMShould you be buying Mind Medicine (MindMed) stock or one of its competitors? The main competitors of Mind Medicine (MindMed) include Agios Pharmaceuticals (AGIO), Indivior (INDV), IDEAYA Biosciences (IDYA), Belite Bio (BLTE), Disc Medicine (IRON), Harmony Biosciences (HRMY), Adaptive Biotechnologies (ADPT), Centessa Pharmaceuticals (CNTA), ARS Pharmaceuticals (SPRY), and Beam Therapeutics (BEAM). These companies are all part of the "pharmaceutical products" industry. Mind Medicine (MindMed) vs. Its Competitors Agios Pharmaceuticals Indivior IDEAYA Biosciences Belite Bio Disc Medicine Harmony Biosciences Adaptive Biotechnologies Centessa Pharmaceuticals ARS Pharmaceuticals Beam Therapeutics Mind Medicine (MindMed) (NASDAQ:MNMD) and Agios Pharmaceuticals (NASDAQ:AGIO) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, dividends, valuation, risk, analyst recommendations, media sentiment, earnings and profitability. Do institutionals & insiders believe in MNMD or AGIO? 27.9% of Mind Medicine (MindMed) shares are held by institutional investors. 2.5% of Mind Medicine (MindMed) shares are held by insiders. Comparatively, 4.3% of Agios Pharmaceuticals shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth. Does the media favor MNMD or AGIO? In the previous week, Agios Pharmaceuticals had 4 more articles in the media than Mind Medicine (MindMed). MarketBeat recorded 5 mentions for Agios Pharmaceuticals and 1 mentions for Mind Medicine (MindMed). Mind Medicine (MindMed)'s average media sentiment score of 1.66 beat Agios Pharmaceuticals' score of 0.45 indicating that Mind Medicine (MindMed) is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Mind Medicine (MindMed) 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Agios Pharmaceuticals 2 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Which has better valuation and earnings, MNMD or AGIO? Agios Pharmaceuticals has higher revenue and earnings than Mind Medicine (MindMed). Mind Medicine (MindMed) is trading at a lower price-to-earnings ratio than Agios Pharmaceuticals, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMind Medicine (MindMed)N/AN/A-$108.68M-$1.29-5.58Agios Pharmaceuticals$36.50M57.21$673.72M$11.243.21 Which has more risk and volatility, MNMD or AGIO? Mind Medicine (MindMed) has a beta of 2.45, indicating that its share price is 145% more volatile than the S&P 500. Comparatively, Agios Pharmaceuticals has a beta of 0.73, indicating that its share price is 27% less volatile than the S&P 500. Do analysts rate MNMD or AGIO? Mind Medicine (MindMed) presently has a consensus target price of $25.50, indicating a potential upside of 254.17%. Agios Pharmaceuticals has a consensus target price of $58.60, indicating a potential upside of 62.53%. Given Mind Medicine (MindMed)'s stronger consensus rating and higher probable upside, equities analysts plainly believe Mind Medicine (MindMed) is more favorable than Agios Pharmaceuticals.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Mind Medicine (MindMed) 0 Sell rating(s) 0 Hold rating(s) 8 Buy rating(s) 3 Strong Buy rating(s) 3.27Agios Pharmaceuticals 0 Sell rating(s) 2 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.71 Is MNMD or AGIO more profitable? Agios Pharmaceuticals has a net margin of 1,798.26% compared to Mind Medicine (MindMed)'s net margin of 0.00%. Agios Pharmaceuticals' return on equity of -2.75% beat Mind Medicine (MindMed)'s return on equity.Company Net Margins Return on Equity Return on Assets Mind Medicine (MindMed)N/A -40.33% -32.13% Agios Pharmaceuticals 1,798.26%-2.75%-2.52% SummaryAgios Pharmaceuticals beats Mind Medicine (MindMed) on 9 of the 16 factors compared between the two stocks. Get Mind Medicine (MindMed) News Delivered to You Automatically Sign up to receive the latest news and ratings for MNMD and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding MNMD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MNMD vs. The Competition Export to ExcelMetricMind Medicine (MindMed)MED IndustryMedical SectorNASDAQ ExchangeMarket Cap$541.72M$2.91B$5.56B$9.03BDividend YieldN/A2.44%5.22%3.99%P/E Ratio-5.5821.5627.6920.25Price / SalesN/A246.41389.63163.10Price / CashN/A42.7336.8958.10Price / Book2.247.518.035.67Net Income-$108.68M-$55.14M$3.18B$249.21M7 Day Performance9.92%4.61%2.93%3.28%1 Month Performance-7.57%0.90%1.72%3.95%1 Year Performance1.69%5.40%34.39%20.98% Mind Medicine (MindMed) Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MNMDMind Medicine (MindMed)3.0611 of 5 stars$7.20+1.7%$25.50+254.2%+1.7%$541.72MN/A-5.5840Positive NewsAGIOAgios Pharmaceuticals4.0089 of 5 stars$33.26-0.6%$58.60+76.2%-15.5%$1.93B$36.50M2.96390Insider TradeINDVIndivior2.0728 of 5 stars$14.74+5.7%$17.00+15.3%+6.5%$1.92B$1.19B-47.551,051News CoverageHigh Trading VolumeIDYAIDEAYA Biosciences2.4059 of 5 stars$21.02-1.6%$53.42+154.1%-35.5%$1.84B$7M-5.8680BLTEBelite Bio2.4435 of 5 stars$57.70-2.3%$96.67+67.5%+31.3%$1.84BN/A-42.4310News CoverageAnalyst ForecastGap UpIRONDisc Medicine3.0359 of 5 stars$52.96-2.8%$96.70+82.6%+17.4%$1.83BN/A-13.5130News CoverageAnalyst ForecastHRMYHarmony Biosciences4.795 of 5 stars$31.60-1.2%$53.63+69.7%+1.0%$1.81B$714.73M12.06200Positive NewsADPTAdaptive Biotechnologies3.3195 of 5 stars$11.65-1.2%$10.57-9.3%+238.3%$1.77B$189.53M-12.14790News CoverageCNTACentessa Pharmaceuticals3.1642 of 5 stars$13.14+0.1%$27.89+112.2%+64.0%$1.75B$6.85M-7.26200SPRYARS Pharmaceuticals3.2381 of 5 stars$17.45-4.1%$31.00+77.7%+81.2%$1.71B$89.15M-109.0690Insider TradeHigh Trading VolumeBEAMBeam Therapeutics2.5203 of 5 stars$17.01+1.3%$48.75+186.6%-13.3%$1.71B$63.52M-3.69510News Coverage Related Companies and Tools Related Companies AGIO Alternatives INDV Alternatives IDYA Alternatives BLTE Alternatives IRON Alternatives HRMY Alternatives ADPT Alternatives CNTA Alternatives SPRY Alternatives BEAM Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:MNMD) was last updated on 7/6/2025 by MarketBeat.com Staff From Our PartnersThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredWhy Elon is funding the “Quantum Power Grid”Elon knows the future isn’t about smarter AI — it’s about powering it. And this new technology is quietly b...True Market Insiders | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredTrump’s BIGGEST setup yet.After another undefeated quarter, “Market Wizard” Larry Benedict is sounding the alarm on a $194 trillion mark...Brownstone Research | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Mind Medicine (MindMed) Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Mind Medicine (MindMed) With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free MNMD Stock Alerts